Unum Group (NYSE:UNM) Issues Quarterly Earnings Results

Unum Group (NYSE:UNM) posted its quarterly earnings data on Tuesday. The financial services provider reported $2.03 earnings per share for the quarter, missing the consensus estimate of $2.14 by ($0.11), Zacks reports. Unum Group had a return on equity of 15.21% and a net margin of 13.76%.

Unum Group Price Performance

UNM stock traded down $0.32 during mid-day trading on Tuesday, hitting $75.91. The stock had a trading volume of 1,256,787 shares, compared to its average volume of 1,048,404. The firm has a fifty day simple moving average of $74.23 and a 200 day simple moving average of $64.84. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.32. Unum Group has a 52 week low of $46.64 and a 52 week high of $77.69. The firm has a market capitalization of $13.86 billion, a P/E ratio of 8.21, a P/E/G ratio of 1.08 and a beta of 0.80.

Unum Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Friday, January 24th will be given a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date is Friday, January 24th. Unum Group’s dividend payout ratio is currently 18.18%.

Analyst Upgrades and Downgrades

UNM has been the topic of several research reports. Truist Financial upped their price target on shares of Unum Group from $70.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday, November 1st. UBS Group upgraded Unum Group to a “hold” rating in a research report on Wednesday, October 9th. Evercore ISI upgraded shares of Unum Group from an “in-line” rating to an “outperform” rating and upped their target price for the company from $67.00 to $84.00 in a research report on Thursday, November 14th. Piper Sandler boosted their price target on shares of Unum Group from $74.00 to $82.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 18th. Finally, Morgan Stanley lifted their price objective on Unum Group from $62.00 to $64.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 30th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $79.00.

Insider Transactions at Unum Group

In other news, EVP Timothy Gerald Arnold sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $76.92, for a total value of $769,200.00. Following the transaction, the executive vice president now owns 54,827 shares in the company, valued at approximately $4,217,292.84. The trade was a 15.43 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Lisa G. Iglesias sold 5,000 shares of Unum Group stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $72.61, for a total transaction of $363,050.00. Following the transaction, the executive vice president now directly owns 35,840 shares of the company’s stock, valued at $2,602,342.40. This represents a 12.24 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 102,914 shares of company stock valued at $7,677,945. Corporate insiders own 0.93% of the company’s stock.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.